CVS Health (NYSE:CVS) Upgraded at Wells Fargo & Company

CVS Health (NYSE:CVS - Get Free Report) was upgraded by investment analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a research report issued on Monday, MarketBeat reports. The firm currently has a $66.00 target price on the pharmacy operator's stock, up from their previous target price of $60.00. Wells Fargo & Company's price target would indicate a potential upside of 17.75% from the stock's current price.

CVS has been the topic of several other research reports. Evercore ISI lifted their price target on CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research note on Tuesday, October 8th. Barclays lowered their target price on CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research note on Thursday, November 7th. Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday. Finally, UBS Group increased their target price on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research report on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $72.78.

CVS Health Stock Performance

Shares of NYSE:CVS traded up $2.86 on Monday, reaching $56.05. 17,377,576 shares of the company's stock were exchanged, compared to its average volume of 11,368,977. The company has a market capitalization of $70.53 billion, a price-to-earnings ratio of 13.50, a PEG ratio of 0.92 and a beta of 0.55. CVS Health has a twelve month low of $52.71 and a twelve month high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a fifty day moving average of $59.23 and a 200-day moving average of $58.60.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm earned $2.21 EPS. On average, research analysts predict that CVS Health will post 5.48 EPS for the current fiscal year.

Institutional Investors Weigh In On CVS Health

Several hedge funds have recently added to or reduced their stakes in the company. Bahl & Gaynor Inc. increased its stake in CVS Health by 11.9% in the 1st quarter. Bahl & Gaynor Inc. now owns 15,833 shares of the pharmacy operator's stock worth $1,263,000 after purchasing an additional 1,680 shares during the period. O Shaughnessy Asset Management LLC raised its holdings in CVS Health by 34.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 86,556 shares of the pharmacy operator's stock worth $6,904,000 after purchasing an additional 22,400 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of CVS Health by 55.5% during the first quarter. Bessemer Group Inc. now owns 73,343 shares of the pharmacy operator's stock valued at $5,849,000 after purchasing an additional 26,173 shares in the last quarter. Lake Street Advisors Group LLC increased its position in shares of CVS Health by 29.3% during the first quarter. Lake Street Advisors Group LLC now owns 12,917 shares of the pharmacy operator's stock valued at $1,030,000 after acquiring an additional 2,930 shares in the last quarter. Finally, Crewe Advisors LLC purchased a new position in shares of CVS Health in the 1st quarter worth $40,000. Institutional investors own 80.66% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.